A phase IV clinical trial of Benvitimod to treat mild-to-moderate psoriasis of adults

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050043

Enrollment

Unknown

Registered

2021-08-16

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Interventions

investigational group:external use

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) aged >=18 year (male or female); 2) diagnosed with mild-to-moderate plaque psoriasis (BSA<10%); 3) subjects who known the trial well and sign the ICF voluntarily.

Exclusion criteria

Exclusion criteria: 1) subjects who need to accept light-treated methods during the medication time; 2) subjects who are allergic to active ingredients or auxiliary materials; 3) subjects accept the light-treated method period; 4) subjects who are not considered to be recruited in this trial.

Design outcomes

Primary

Measure	Time frame
PSAI;PGA;	—

Countries

China

Contacts

Public ContactShen Juan

shenjuan@tianjipharma.com.cn+86 13810517614

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026